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Major abdominal surgeryAbstract Background: A lot of researches have been done to ﬁnd an adjuvant in regional anesthe-
sia that inhibits pain without any side effects.
Aim: This study was conducted to evaluate the onset, extent and duration of sensory and motor
block, and side effects of morphine and dexmedetomidine when used as adjuvants to levobupiva-
caine in epidural anesthesia in major abdominal surgery.
Materials and methods: A prospective randomized study was conducted on 60 patients classiﬁed as
American Society of Anesthesiologists status I and status II who underwent abdominal surgery.
Patients were randomly allocated into two groups; group I levobupivacaine morphine group
(LM), group II: levobupivacaine dexmedetomidine group (LD), comprising of 30 patients each.
Group I patients received 20 ml of 0.5% levobupivacaine (150 mg) and 0.005 % morphine. Group
II patients received 20 ml of 0.5% levobupivacaine and 1.5 lg/kg dexmedetomidine. The onset,
extent and duration of sensory and motor blocks, abdominal muscle relaxation, and side effects
were recorded.
Results: There were no statistically signiﬁcant differences between the two groups as regards onset
of sensory block or sensory level achieved. Time to reach motor block was shorter in the LM group
than the LD group. There were no signiﬁcant differences between the time of total regression of
sensory or motor black and abdominal muscle relaxation. As regards side effects, more patients
in the LM group suffered from pruritis and more patients suffered from dry mouth in the LD
group.
Conclusion: Dexmedetomidine is a good alternative to morphine as an adjuvant to levobupivacaine
in epidural anesthesia in major abdominal surgeries.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.
138 M.M. Kamal, S.M. Talaat1. Introduction
Major abdominal surgery may be done by using regional
(spinal or epidural) or general anesthesia. Nowadays, regional
(spinal or epidural) anesthesia is the preferable mode of anes-
thesia. Epidural anesthesia reduces the perioperative stress re-
sponses to surgery and improves surgical outcome [1]. Local
anesthetics and opioids are the drugs most widely used in epi-
dural anesthesia which is either by single injection or by infu-
sion (see Tables 1–5).
Levobupivacaine is the isolated S() isomer of bupivacaine
and is less cardiotoxic [2,3]. Dexmedetomidine is the selective
a2-adrenoceptor agonist with analgesic potency, sedative
properties and causes minimal respiratory depression when
used as adjuvant to regional anesthesia [4–6].
The antinociceptive mechanisms of this drug when used in
epidural anesthesia are spinally mediated as it has no analgesic
effect when given systemically. It is highly lipid soluble and ap-
pears rapidly in CSF and has high binding afﬁnity to a2 recep-
tors in the spinal cord [7].
Morphine is the ‘‘gold standard’’ opioid for neuraxial anal-
gesia during and after surgery [8,9]. This is because of its long
action activity as it is water soluble and it crosses biological
membranes as dural membrane slowly. Its analgesic effect is
due to drug diffusion into cerebrospinal ﬂuid (CSF) across
the dural membrane and its binding to opioid receptors in
the dorsal horn of the spinal cord and is also due to supraspi-
nal action for both rostral spread in cerebrospinal ﬂuid and
systemic blood absorption of the drug [10,11].
Nowadays, the use of adjuvant with local anesthetics is
essential as it prolongs the duration of work, gives better suc-
cess rate and increases patient satisfaction.
This study makes a comparison between two adjuvants, one
is opioid (morphine) and the other is a2 agonist (dexmedetom-
idine), used with levobupivacaine in major abdominal surgery
as regards onset, extent, duration of block, muscle relaxation
and side effects.
2. Patient and methods
After obtaining ethical committee approval and written in-
formed consent, 60 ASA physical status I and status II patients
aged 25–45 years, of both sexes, scheduled for abdominal sur-
gery under epidural anesthesia were included in this study. Sur-
gical procedures included colectomy, radical prostatectomy
and abdominoperineal resection. Patients with history ofTable 1 Demographic data.
Group I (n= 30)
Age (yr) Range 25.00–45.00
Mean (SD) 35.00(7.86)
Sex N (%) Female 15.00(50)
Male 15.00(50)
Weight (kg) Range 70.00–90.00
Mean (SD) 80.54(8.44)
Height (cm) Range 150.00–170.00
Mean (SD) 162.11(5.49)
ASA N (%) I 17.00(56.67)
II 13.00(43.33)uncontrolled hypertension, cardiac, respiratory, hepatic, neu-
rological, neuromuscular disease; with allergy to the used
drugs, contraindication or failure of epidural anesthesia were
excluded from the study.
Patients were monitored by ECG, pulse oximetry (SPO2)
and non-invasive blood pressure (NIBP).
After infusion of 500 ml of lactated Ringer’s solution, pa-
tients were put in the sitting position. 3 ml of lidocaine was
used to inﬁltrate the skin and subcutaneous tissues.
A 17 gauge Tuohy needle was used at T10–T12. After loss
of resistance, the epidural catheter was advanced 3–4 cm into
the epidural space. Any evidence of needle or catheter entry
into an epidural vein or into the CSF excluded the patient from
this study. A test dose of 3 ml of 2% lignocaine solution con-
taining adrenaline 1: 200,000 was injected. After 4–6 min of
injecting the test dose and excluding intravascular or subarach-
noid injection, patients were allocated to one of two groups in
a double blinded fashion based on computer-generated code,
group I: levobupivacaine and morphine (LM) in which 20 ml
of 0.5% levobupivacaine (150) and 0.005% morphine was
administered in the epidural catheter, group II: levobupiva-
caine and dexmedetomidine (LD) in which 20 ml of 0.5% lev-
obupivacaine (150 mg) and 1.5 lg/kg dexmedetomidine was
administered in the epidural catheter. The drug syringes were
prepared by an anesthetist not oriented with the idea of the
study. Block was achieved for the surgery. Sensory block
was assessed using the blunt end of a 27-gauge needle until
an appropriate block was achieved. If an adequate sensory
block was not achieved after 20 min from injection, an addi-
tional dose of 5 ml of 0.5% levobupivacaine was given. If no
adequate sensory block was achieved after 30 min of injection,
the patient was withdrawn from the study. Motor blockade
was assessed by using the modiﬁed Bromage scale [12] (Bro-
mage 0: The patient is able to move the hip, knee and ankle;
Bromage 1: The patient is unable to move the hip but able
to move the knee and the ankle; Bromage 2: The patient is un-
able to move the hip and knee but able to move the ankle; Bro-
mage 3: The patient is unable to move the hip, knee and ankle).
The time to reach the peak sensory level and Bromage 3 motor
block was recorded before surgery. The regression time for
sensory and motor block was recorded in Post-anesthesia care
unit (PACU). All durations were calculated from the time of
epidural injection.
The overall quality of intra-operative muscle relaxation
(poor, fair, good or excellent) was evaluated by the surgeon
at the end of the surgery.Group II (n= 30) t or chi-square
t/X2 P-value
25.00–45.00 1.63 0.11
38.33(7.99)
14.00(46.67) 0.00 1.00
16.00(53.33)
70.00–90.00 0.96 0.34
82.45(6.89)
155.00–175.00 0.70 0.49
160.88(7.88)
18.00(60.00) 0.00 1.00
12.00(40.00)
Table 2 Block characteristics.
Group I (n= 30) Group II (n= 30) t or chi-square
t/X2 P-value
Onset of sensory block 11.50(5.40) 12.60(5.90) 0.75 0.45
Time to reach maximum sensory level 20.30(5.60) 22.40(9.40) 1.05 0.30
Time to reach motor block 24.20(3.10) 27.30(2.10) 4.54 <0.001*
Time to regression of sensory 360.00(71.10) 390.00(87.60) 1.46 0.15
Time of total regression of motor block 420.00(89.70) 400.00(96.20) 0.83 0.41
Maximum sensory block level N (%) T7 8.00(26.67) 6.00(20.00) 0.87 0.83
T8 10.00(33.33) 9.00(30.00)
T9 7.00(23.33) 10.00(33.33)
T10 5.00(16.67) 5.00(16.67)
Values presented as mean (SD).
* Means statistically signiﬁcant.
Table 3 Degree of abdominal muscle relaxation.
Group I (n= 30) Group II (n= 30) Total Chi-square
N % N % N % X2 P-value
Excellent 7.00 23.33 5.00 16.67 12.00 20.00 0.87 0.83
Good 10.00 33.33 10.00 33.33 20.00 33.33
Fair 10.00 33.33 11.00 36.67 21.00 35.00
Poor 3.00 10.00 5.00 16.67 8.00 13.33
Table 4 Side effects observed in both groups.
Group I (n= 30) Group II (n= 30) Total Chi-square
N % N % N % X2 P-value
Nausea 10 33.33 5 16.67 15 25.00 2.256 0.133
Vomiting 8 26.67 3 10.00 11 18.33 2.869 0.090
Pruritis 5 16.67 0 0.00 5 8.33 7.387 0.007*
Dry mouth 0 0.00 6 20.00 6 10.00 6.570 0.010*
Respiratory depression 0 0.00 0 0.00 0 0.00
* Means statistically signiﬁcant.
Table 5 Sedation score in both groups.
Sedation score Group I (n= 30) Group II (n= 30) Total Chi-square
N % N % N % X2 P-value
1 5 16.67 3 10.00 8 13.33 1.83 0.40
2 15 50.00 12 40.00 27 45.00
3 10 33.33 15 50.00 25 41.67
4 0 0.00 0 0.00 0 0.00
5 0 0.00 0 0.00 0 0.00
Comparative study of epidural morphine and epidural dexmedetomidine 139The two groups were monitored preoperatively, intraoper-
atively for heart rate, non-invasive blood pressure and O2 sat-
uration (SpO2). Hypotension was deﬁned as systolic blood
pressure <90 mmHg or >30% decrease in baseline values
and was treated by ﬂuids and vasopressors.
Tachycardia was deﬁned as heart rate >100/min. Brady-
cardia was deﬁned as heart rate <55/min and was treated by
0.5 mg of atropine injection. Intraoperative nausea, vomiting,
pruritus, sedation or any other side effects were recorded.
Sedation was assessed by sedation score (1: alert and
awake, 2: arousable to verbal command, 3: arousable withgentle tactile stimulation, 4: arousable with vigorous shaking,
5: unarousable).
3. Statistical methods
Data were presented as mean ± SD. t-test was used to com-
pare the two groups for quantitative data and chi-square test
was used for qualitative data by SPSS V18. Value of
P< 0.05 was considered statistically signiﬁcant. The primary
outcome upon which we calculated the sample size was the
time to reach motor block. We made a pilot study from group
140 M.M. Kamal, S.M. TalaatI and group II (5 cases from each group) and we found the dif-
ference between 2 means 1.7 by SD from group I 2.8 and SD
from group II 2.6. We found the minimal sample size was 54
by a (type I error) 0.05 and b (type II error) 0.1 with power
of test 90%.
4. Results
There was no statistically signiﬁcant difference between the
two groups in any of the demographic data.
There was no statistical signiﬁcance between the two groups
as regards the onset of sensory block, time to total regression
of motor or sensory block or maximum sensory block level.
Time to reach total motor block was signiﬁcantly shorter in
the (LM) group than the (LD) group.
There was no statistically signiﬁcant difference between the
two groups in the degree of muscle relaxation.
There was no statistically signiﬁcant difference as regards
nausea vomiting or respiratory depression. However, 5 pa-
tients (16.6%) in the LM group suffered from pruritis while
no patient suffered from it in the LD group, and 6 patients
(20%) suffered from dry mouth in the LD group while no pa-
tient suffered from it in the LM group.
There was no statistically signiﬁcant difference between the
two groups as regards sedation score.
No remarkable changes in the hemodynamic variables were
recorded in both groups.5. Discussion
Nowadays, a lot of adjuvants are used with local anesthetics in
the epidural anesthesia. The aim of these adjuvants is to fasten
and prolong the sensory and motor block and produce more
sedation and analgesia. In this study, morphine was compared
with dexmedetomidine (a2 agonist) as adjuvants to levobupiva-
caine in epidural anesthesia. Opioids are often combined with
epidural local anesthetics to improve the quality of analgesia
and decrease local anesthetic requirements and motor blockade
[13]. Morphine represents the ‘‘gold standard’’ opioid for neur-
axial analgesia in the major surgeries [8,9]. Dexmedetomidine, a
highly selective a2 adrenoceptor agonist, is used in combination
with local anesthetics for sedation and analgesia. Dexmedetom-
idine when combined with spinal bupivacaine prolongs the sen-
sory block by depressing the release of c-ﬁber transmitter and
by hyperpolarization of post-synaptic dorsal horn neurons
[14]. Motor block prolongation by a2-adrenoceptor agonists
may result from binding of these agonists to motor neurons
in the dorsal horn of the spinal cord [15].
This study was the ﬁrst study to compare morphine and
dexmedetomidine as adjuvants to levobupivacaine in epidural
anesthesia. In this study, it was found that both of them were
alike in the onset and duration of sensory and motor block,
but morphine gave faster motor block. Both of them were
comparable in the time of regression of sensory and motor
block and abdominal muscle relaxation degree.
As regards side effects, more patients suffered from pruritis
in the levobupivacaine morphine group and more patients suf-
fered from dry mouth in the levobupivacaine dexmedetomi-
dine group. There was no difference in the sedation score
between the two groups. All the side effects were well tolerated
by the patients.Kanazi and colleagues [16] found in their study that the
supplementation of bupivacaine with a low dose dexmedetom-
idine produced signiﬁcantly longer sensory and motor blocks
than bupivacaine alone, and they found that dexmedetomidine
produced a signiﬁcantly shorter onset of motor block but in
comparison with bupivacaine alone and in our study morphine
accelerated the onset of motor block when added to levobup-
ivacaine other than dexmedetomidine. On the other hand,
Gupta and associates [17] found that there was no difference
in the onset time to Bromage 3 motor block on comparing
intrathecal bupivacaine dexmedetomidine with intrathecal
bupivacaine fentanyl but the regression to Bromage 0 motor
block was signiﬁcantly slower on adding dexmedetomidine.
A study done by Odette and Lesley [18] on dogs showed that
epidural bupivacaine dexmedetomidine group had a slower re-
turn of motor function than bupivacaine morphine group,
which is different from our study that showed no statistical dif-
ference between the two groups in time to total regression of
motor block.
Al-Mustafa et al. [19] and Al-Ghanem et al. [20] used dex-
medetomidine but as an intrathecal adjuvant to bupivacaine
and found that its effect was dose-dependent and that its use
accelerated the onset of sensory block to reach T10
dermatome.
Bajwa and his team [21] showed in their study that dex-
medetomidine was a better adjuvant than clonidine in epidural
anesthesia for patient comfort, superior sedative and anxiolytic
properties, intra-operative and postoperative analgesia.
Crews et al. [22] found in their study that the use of contin-
uous levobupivacaine in addition to morphine via a thoracic
epidural catheter produced a segmental sensory block and
excellent analgesia.6. Conclusion
The use of dexmedetomidine as an adjuvant to levobupiva-
caine seems to be a good alternative to the use of morphine
in epidural anesthesia in major abdominal surgery. Both of
them provide adequate sensory, motor block and abdominal
muscle relaxation. Their side effects are well tolerated by the
patients. Further studies may be needed to conﬁrm this result.Conﬂict of interest
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